Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
04 June 2019 | Story Valentino Ndaba | Photo Charl Devenish
Prof Cathryn Tonne
Air pollution not only costs lives, it costs money too. Pictured is Prof Cathryn Tonne presenting a guest lecture on air pollution at the Bloemfontein Campus.

Health effects associated with ambient air pollution (AAP) have been well documented. Subsequently, the relationship between pollution and financial outcomes have also become a focus for case studies globally. An Environmental Research journal article revealed that “low and middle-income countries are disproportionately affected by the global burden of adverse health effects caused by AAP”. 

A high price to pay

In 2012, high concentrations of air pollution caused 7.4% of all deaths, costing South Africa up to 6% of its Gross Domestic Product. According to the recent International Growth Centre study conducted by senior University of Cape Town researchers, this is a direct consequence of the country’s heavy dependence of fossil fuels, a source of health-damaging air pollution and greenhouse pollutants.

Stunted human and economic growth

These South African statistics are attested to by Prof Cathryn Tonne who recently presented a guest lecture on air pollution which was hosted by the University of the Free State (UFS) Business School.

“Air pollution can affect economic development through several pathways, and health is an important one. Air pollution is linked to shorter life expectancy, chronic disease, asthma exacerbation and many other health outcomes that result in absenteeism from work and school. These have large direct costs to the health system.” 

Prof Tonne says that air pollution exposure in children is linked to reduced cognitive development, with important impacts on human capital. As a result, children are not reaching their full potential in terms of neurodevelopment, which has an effect on their income prospects and the economy as a whole. 

Resolving a looming disaster

Technology may be employed to radically clean the air. Cities need to lead in the reduction of air pollution by promoting renewable energy, using active transport such as walking or cycling, and investing in infrastructure to make this safe and attractive. 

With researchers playing a major role in strengthening the case for aggressive air pollution control, the government needs to implement policies in order to control sources of air pollution. This global health and economic issue also requires individuals and communities to play their part to improve air quality.

News Archive

UFS research on yeast nanorobotics
2006-05-09

Ten members from the University of the Free State's (UFS) Lipid Biotechnology Research Group in the Department of Microbial, Biochemical and Food Biotechnology will be presenting their research  on yeast nanorobotics (nanotechnology) at three international conferences in Europe during May and June 2006.

 

It is one of the biggest group of students from the department to present their research overseas.  

The conferences to be attended include the 2nd International Conference on Non Mammalian Eicosanoids, Bioactive Lipids and Plant Oxylipins held in Berlin, Germany; the 3rd European Conference on Computational Mechanics (ECCM-2006) held in Lisbon, Portugal and the 25th International Specialised Symposium on Yeasts (ISSY 2006) held in Helsinki, Finland.  The UFS Lipid Biotechnology Group is also co-organising the conference in Berlin.

The group members are in front from the left Ms Chantel Swart (M Sc student), Ms Ntsoaki Leeuw (M Sc student) and Ms Monique Goldblatt (M Sc student).
Middle from the left Mr Olihile Sebolai (Ph D student and recipient of the Free State Premier Excellence Award), Ms Ané van Heerden (M Sc student) and Dr Catrine Strauss (post-doctoral student).
At the back are from the left Mr Desmond Ncango (M Sc), Dr Carlien Pohl (Senior Researcher), Prof Pieter van Wyk (Head: UFS Center for Confocal and Electron Microscopy) and Prof Lodewyk Kock (Head: UFS Lipid Biotechnology Group).
Photo: Stephen Collett

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept